| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.007 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.008 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |